Evidence map›Paper›PMID 37476494›Full record

ArticleFrontiers in endocrinology2023

Investigating causal associations among gut microbiota, metabolites, and liver diseases: a Mendelian randomization study.

Lilong Zhang, Liuliu Zi, Tianrui Kuang, Kunpeng Wang, Zhendong Qiu, Zhongkai Wu, Li Liu, Rongqiang Liu, Peng Wang, Weixing Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. The Role ofInternational journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Dietary supplementation with walnut (Frontiers in veterinary science · 2026
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Effect of the total flavonoids ofFrontiers in pharmacology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Lilong ZhangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Liuliu ZiDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Tianrui KuangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Kunpeng WangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Zhendong QiuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Zhongkai WuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Li LiuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Rongqiang LiuDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Peng WangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Weixing WangDepartment of General Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Wuhan University · CNRenmin Hospital of Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: There is some evidence for an association between gut microbiota and nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), and viral hepatitis, but no studies have explored their causal relationship. Methods: Instrumental variables of the gut microbiota (N = 13266) and gut microbiota-derived metabolites (N = 7824) were acquired, and a Mendelian randomization study was performed to explore their influence on NAFLD (1483 European cases and 17,781 European controls), ALD (2513 European cases and 332,951 European controls), and viral hepatitis risk (1971 European cases and 340,528 European controls). The main method for examining causality is inverse variance weighting (IVW). Results: IVW results confirmed that Conclusion: In conclusion, our research supported causal links between the gut microbiome and its metabolites and NAFLD, ALD, and viral hepatitis.

Indexed as

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseAlanineButyratesEubacterialesHumansMendelian Randomization AnalysisAlanineButyratesthreonic acidalcoholic liver diseasegut microbiotagut microbiota-derived metabolitesmendelian randomization analysisnonalcoholic fatty liver diseaseviral hepatitis

Identifiers

PMID37476494
PMCPMC10354516
OpenAlexW4383198685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.